Glyburide-induced hemolysis in myelodysplastic syndrome
نویسندگان
چکیده
منابع مشابه
Benzene-induced myelodysplastic syndrome.
In various industries benzene is used for cleaning, stain removal, and dilution and as an adhesive. The petrochemical industry uses benzene as a raw material for styrene, alkyl benzene, and caprolactam. Moreover, aromatic compounds are added to gasoline as a substitute for alkyl lead compounds. Although atmospheric lead pollution is reduced, the concentration of benzene released into the air is...
متن کاملDeferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome*
Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal symptoms and increase in serum creatinine and transaminases, skin rashes, such as maculopapular and urticarial eruptions, have also been reported. This study reports a case...
متن کاملMyelodysplastic syndrome.
The last decade has witnessed a multistep evolution in the understanding of the natural history, clinical manifestations, and some of the molecular mechanisms that underlie the ineffective hematopoiesis and leukemic transformation in the myelodysplastic syndrome (MDS). The international prognostic scoring system, FAB, and WHO classifications have helped define specific subgroups with their char...
متن کاملMyelodysplastic Syndrome
The hallmark of neoplastic disease, including myelodysplastic syndrome (MDS), is clonal proliferation of cells. Clonal proliferation is the consequence of acquired somatic mutation that confers a proliferative advantage to cells. For the myelodysplastic syndrome, the ability to identify clonally derived cells has provided valuable information about the molecular pathogenesis of the disease, the...
متن کاملErythropoietin-induced deep vein thrombosis in myelodysplastic syndrome.
We report a rare case of deep vein thrombosis (DVT) secondary to erythropoietin (EPO) in an 89-year-old patient with myelodysplastic syndrome (MDS). The incidence of EPO-induced thrombotic episode increases with an absolute increase of hemoglobin (Hb) beyond >12 gm/dL or rate of increase of Hb level >1 gm/dL every 2 weeks.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Care
سال: 2000
ISSN: 0149-5992,1935-5548
DOI: 10.2337/diacare.23.1.129b